Literature DB >> 14671423

Los function and obesity: the impact of untreated obesity, weight loss, and chronic gastric balloon distension.

E M H Mathus-Vliegen1, M van Weeren, P V van Eerten.   

Abstract

BACKGROUND/AIMS: In obesity, many gastro-oesophageal reflux promoting factors are present. Weight reduction is advised to symptomatic overweight subjects. The aim of the present study was to investigate the influences of untreated obesity, weight loss, and chronic gastric balloon distension on the lower oesophageal sphincter (LOS) function.
METHODS: Patients entering a randomized, double-blind, sham-controlled study of balloon treatment, consisting of 4 months of either sham balloon or balloon treatment followed by 4 months of balloon treatment. Manometry and 24-hour pH measurements were performed at the start of the study and after 13 and 26 weeks.
RESULTS: Before treatment, LOS dysfunction was present in 7 of 32 patients (21.9%). Increased upright and supine reflux was present in 8 patients (25%). Sham treatment resulted in a weight loss of 9.7% with improved LOS function (a significant 0.6-cm increase in LOS length and a non-significant 2.6 mm Hg higher LOS pressure) and in a significantly decreased upright reflux (acid reflux time decreasing from 8.0 to 5.5% and number of meal-related and postprandial reflux episodes decreasing from 49 to 32). These improved values deteriorated after 4 months of balloon placement, with significantly increasing total, upright, and supine reflux to 7.5, 7.6, and 6.7% of the time, respectively, with oesophageal lesions after an overall 17.8% weight loss. Four months of balloon treatment induced a similar weight loss (9.9%) with significantly increased supine reflux from 1.6 to 6.7% of the time. After a second 4-month balloon period and an overall 13.8% weight loss, LOS and reflux values returned towards baseline values. A comparison of both groups demonstrated the adverse effects of balloon positioning after a period of substantial sham-induced weight loss.
CONCLUSIONS: Impaired LOS function and increased gastro-oesophageal reflux were observed in one quarter of the untreated obese subjects. Weight loss ameliorated manometry and pH values, but subsequent balloon positioning tended to counteract these beneficial changes. In patients on balloon treatment from the start, adverse effects seemed to wear off with prolonged treatment. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14671423     DOI: 10.1159/000075525

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  12 in total

Review 1.  Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations.

Authors:  J H-E Kang; J Y Kang
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

Review 2.  Randomized sham-controlled trials in endoscopy: a systematic review and meta-analysis of adverse events.

Authors:  Allison R Schulman; Violeta Popov; Christopher C Thompson
Journal:  Gastrointest Endosc       Date:  2017-08-09       Impact factor: 9.427

Review 3.  Filling the Void: A Review of Intragastric Balloons for Obesity.

Authors:  Patrick Laing; Tuan Pham; Linda Jo Taylor; John Fang
Journal:  Dig Dis Sci       Date:  2017-04-18       Impact factor: 3.199

4.  Prevalence and risk factors for gastroesophageal reflux disease in an impoverished minority population.

Authors:  Frank K Friedenberg; Jitha Rai; Vishwas Vanar; Charles Bongiorno; Deborah B Nelson; Mayur Parepally; Arashdeep Poonia; Amol Sharma; Shaun Gohel; Joel E Richter
Journal:  Obes Res Clin Pract       Date:  2010-10       Impact factor: 2.288

5.  Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.

Authors:  Shobna J Bhatia; Govind K Makharia; Philip Abraham; Naresh Bhat; Ajay Kumar; D Nageshwar Reddy; Uday C Ghoshal; Vineet Ahuja; G Venkat Rao; Krishnadas Devadas; Amit K Dutta; Abhinav Jain; Saurabh Kedia; Rohit Dama; Rakesh Kalapala; Jose Filipe Alvares; Sunil Dadhich; Vinod Kumar Dixit; Mahesh Kumar Goenka; B D Goswami; Sanjeev K Issar; Venkatakrishnan Leelakrishnan; Mohandas K Mallath; Philip Mathew; Praveen Mathew; Subhashchandra Nandwani; Cannanore Ganesh Pai; Lorance Peter; A V Siva Prasad; Devinder Singh; Jaswinder Singh Sodhi; Randhir Sud; Jayanthi Venkataraman; Vandana Midha; Amol Bapaye; Usha Dutta; Ajay K Jain; Rakesh Kochhar; Amarender S Puri; Shivram Prasad Singh; Lalit Shimpi; Ajit Sood; Rajkumar T Wadhwa
Journal:  Indian J Gastroenterol       Date:  2019-12-05

Review 6.  Body weight, lifestyle, dietary habits and gastroesophageal reflux disease.

Authors:  Davide Festi; Eleonora Scaioli; Fabio Baldi; Amanda Vestito; Francesca Pasqui; Anna Rita Di Biase; Antonio Colecchia
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

Review 7.  Lifestyle Intervention in Gastroesophageal Reflux Disease.

Authors:  Eivind Ness-Jensen; Kristian Hveem; Hashem El-Serag; Jesper Lagergren
Journal:  Clin Gastroenterol Hepatol       Date:  2015-05-06       Impact factor: 11.382

Review 8.  Intragastric balloon for obesity.

Authors:  M Fernandes; A N Atallah; B G O Soares; S Humberto; S Guimarães; D Matos; L Monteiro; B Richter
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

9.  Is Endoscopy Really Necessary for Placing Intragastric Balloons?

Authors:  Elisabeth M H Mathus-Vliegen
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

Review 10.  To what extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials.

Authors:  Wayne B Jonas; Cindy Crawford; Luana Colloca; Ted J Kaptchuk; Bruce Moseley; Franklin G Miller; Levente Kriston; Klaus Linde; Karin Meissner
Journal:  BMJ Open       Date:  2015-12-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.